Owens Julia C. 4

4 · Millendo Therapeutics, Inc. · Filed Dec 11, 2018

Form 4

Period: 2018-12-07

DirectorPresident and CEO

Transactions

Award
Employee Stock Option (right to buy)
2018-12-07+151,600→ 151,600 total
Exercise: $4.44Exp: 2026-01-27→ Common Stock (151,600 underlying)
Award
Employee Stock Option (right to buy)
2018-12-07+60,179→ 60,179 total
Exercise: $1.08Exp: 2022-08-29→ Common Stock (60,179 underlying)
Award
Employee Stock Option (right to buy)
2018-12-07+174,839→ 174,839 total
Exercise: $16.40Exp: 2028-08-23→ Common Stock (174,839 underlying)
Award
Common Stock
2018-12-07+74,400→ 74,400 total

Footnotes (7)

[F1]Received in exchange for 1,000,000 shares of Millendo Therapeutics, Inc. ("Millendo") common stock in connection with merger of Millendo Therapeutics, Inc. into the Issuer (the "Merger").
[F2]Fully vested.
[F3]Received in connection with the Merger in exchange for a stock option to acquire 808,867 shares of Millendo common stock for $0.08 per share.
[F4]Twenty-five percent (25%) of the shares subject to the option vested on January 28, 2017, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
[F5]Received in connection with the Merger in exchange for a stock option to acquire 2,037,648 shares of Millendo common stock for $0.33 per share.
[F6]Twenty-five percent (25%) of the shares subject to the option shall vest on August 20, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
[F7]Received in connection with the Merger in exchange for a stock option to acquire 2,350,000 shares of Millendo common stock for $1.22 per share.

Documents

1 file